KATIA CALLEJA: Open Payments
NPI 1366109860 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 48 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $423 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 11 | $312 |
| Otsuka America Pharmaceutical, Inc. | 17 | $259 |
| Almatica Pharma LLC | 10 | $238 |
| ABBVIE INC. | 3 | $71 |
| Alkermes, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: REXULTI, LOREEV XR, VRAYLAR, ARISTADA, FANAPT, AUSTEDO XR, COBENFY, SPRAVATO.
Industry payments across FL — which companies pay providers there.
